Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 2 Study of Suberoylanilide Hydroxamic Acid (SAHA) in Subjects With Locally Advanced, Recurrent or Metastatic Adenoid Cystic Carcinoma (ACC)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01175980
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:37.819324+00:00
Published At
2020-08-03T00:00:00+00:00
Record Updated At
2020-08-03
Results Posted At
2020-08-03
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Recurrent Oral Cavity Adenoid Cystic Carcinoma", "Recurrent Salivary Gland Carcinoma", "Salivary Gland Adenoid Cystic Carcinoma", "Stage III Major Salivary Gland Cancer AJCC v7", "Stage III Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7", "Stage IVA Major Salivary Gland Cancer AJCC v7", "Stage IVA Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7", "Stage IVB Major Salivary Gland Cancer AJCC v7", "Stage IVB Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7", "Stage IVC Major Salivary Gland Cancer AJCC v7", "Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7", "Tongue Carcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2020-08-03"
protocolSection.identificationModule.nctId
"NCT01175980"
protocolSection.identificationModule.officialTitle
"A Phase 2 Study of Suberoylanilide Hydroxamic Acid (SAHA) in Subjects With Locally Advanced, Recurrent or Metastatic Adenoid Cystic Carcinoma (ACC)"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2020-08-03"

Study condition terms

  • Recurrent Oral Cavity Adenoid Cystic Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Salivary Gland Carcinoma (protocolSection.conditionsModule.conditions)
  • Salivary Gland Adenoid Cystic Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage III Major Salivary Gland Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage III Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
  • Stage IVA Major Salivary Gland Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IVA Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
  • Stage IVB Major Salivary Gland Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IVB Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
  • Stage IVC Major Salivary Gland Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
  • Tongue Carcinoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.